These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10068263)
1. Drug development in solid tumors: personal perspective of Dr. Emil J Freireich's contributions. Carbone PP Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2614-22. PubMed ID: 10068263 [TBL] [Abstract][Full Text] [Related]
2. Curative cancer chemotherapy. Frei E Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603 [TBL] [Abstract][Full Text] [Related]
3. Confrontation, passion, and personalization. Emil J. Freireich. Frei E Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2554-62. PubMed ID: 9815656 [No Abstract] [Full Text] [Related]
4. [Specific treatment situations in metastatic colorectal cancer]. Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307 [TBL] [Abstract][Full Text] [Related]
5. Freireich's laws in the treatment of sarcomas. Benjamin RS Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2648-54. PubMed ID: 10068268 [No Abstract] [Full Text] [Related]
6. Diffuse aggressive lymphoma. Fisher RI; Miller TP; O'Connor OA Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685 [TBL] [Abstract][Full Text] [Related]
7. The birth of the subspecialty of medical oncology and examples of its early scientific foundations. Band PR J Clin Oncol; 2010 Aug; 28(22):3653-8. PubMed ID: 20567013 [TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
9. Progress in the systemic treatment of cancer. Concepts, trials, drugs, and biologics. Carbone PP Cancer; 1990 Feb; 65(3 Suppl):625-33. PubMed ID: 2302652 [TBL] [Abstract][Full Text] [Related]
10. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related]
11. Summary of the first Emil J Freireich symposium. Bast RC Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2708-10. PubMed ID: 10068278 [No Abstract] [Full Text] [Related]
13. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736 [TBL] [Abstract][Full Text] [Related]
14. Rethinking the randomized clinical trial: the 21st century application of Freireich's laws. [An interview with Emil J Freireich by H&O]. Freireich EJ Clin Adv Hematol Oncol; 2008 Nov; 6(11):801-4. PubMed ID: 19194362 [No Abstract] [Full Text] [Related]
15. [Chemotherapy cancer treatment during the past sixty years]. Furue H Gan To Kagaku Ryoho; 2003 Oct; 30(10):1404-11. PubMed ID: 14584272 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture. Bonadonna G Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867 [TBL] [Abstract][Full Text] [Related]
18. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
19. A history of cancer chemotherapy. DeVita VT; Chu E Cancer Res; 2008 Nov; 68(21):8643-53. PubMed ID: 18974103 [TBL] [Abstract][Full Text] [Related]